Medo Specia Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.93 M
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -49.91%
- Profit Growth 130.57%
- Ebitda 119.45%
- Net Worth 2.22%
- Total Assets 2.97%
About Medo Specia Pharma
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2000PTC129264
-
Company No.
129264
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 2000
-
Date of AGM
07 Jun 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medo Specia Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Balasubramanian
|
Director | 03-Aug-2009 | Current |
|
Ashwin Prasad
|
Director | 27-Jul-2016 | Current |
Financial Performance of Medo Specia Pharma.
Medo Specia Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 49.91% decrease. The company also saw a substantial improvement in profitability, with a 130.57% increase in profit. The company's net worth moved up by a moderate rise of 2.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medo Specia Pharma?
In 2021, Medo Specia Pharma had a promoter holding of 50.22% and a public holding of 49.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tidal Healthcare Private LimitedKrishna Balasubramanian and Ashwin Prasad are mutual person
-
Tidal Laboratories Private LimitedKrishna Balasubramanian is a mutual person
-
Medo Specia Laboratories Private LimitedKrishna Balasubramanian and Ashwin Prasad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medo Specia Pharma?
Unlock and access historical data on people associated with Medo Specia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medo Specia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medo Specia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
